PTCT   $44.64  -0.51% Market Closed After Close 45.0 0.81%

PTC Therapeutics Inc
Total Cash 1.09B
totalCashPerShare 14.213
EBITDA 12.72M
Total Debt 2.48B
quickRatio 2.1
currentRatio 2.227
Total Revenue 900.45M
debtToEquity
Revenue/Share 11.844
ROA -0.073920004
ROE
grossProfits
freeCashflow -84.33M
operatingCashflow -115.50M
earningsGrowth
revenueGrowth -0.127
grossMargins 0.33063
ebitdaMargins 0.01413
operatingMargins -0.17865999
profitMargins -0.53253
enterpriseValue 4.53B
forwardPE -10.927807
floatShares 60.78M
sharesOutstanding 76.92M
sharesShort 4.66M
sharesShortPriorMonth 5.22M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.06%
Short Ratio help_outline 5.65%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue -12.746
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -479.52M
trailingEps -6.31%
forwardEps -3.74%
enterpriseToEbitda 356.24
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.44 3Q 2024
institutionsCount 300
lastUpdated Nov. 6, 2024, 4:29 p.m.